AMGN
AMGEN Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Amgen Inc. is a leading multinational biopharmaceutical company headquartered in Thousand Oaks, California, recognized for its pioneering therapies developed through recombinant DNA technology. The company focuses on key therapeutic areas including oncology, nephrology, and inflammation, utilizing i...
$355.20
+0.32% (+$1.14)
Volume
2.73M
52W High
$391.29
52W Low
$263.82
Market Cap
$186.16B
What to Watch This Quarter
Based on historical dataConsensus EPS
$5.59
Whisper EPS
$5.86
4.8% above consensus
Last Quarter
$5.15
Current Streak
1 Beat
Avg Surprise (4Q)
+3.89%
Next Earnings Report
Reports in 50 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Apr 30, 2026
1-Day:
-4.75%
5-Day:
-4.81%
Q1 2026
Apr 29, 2026
1-Day:
+2.43%
5-Day:
-4.19%
Q4 2025
Feb 3, 2026
1-Day:
+8.15%
Q4 2025
Feb 2, 2026
1-Day:
-1.77%
Revenue & Financial Performance
Revenue Whisper
$9.11B
TWN Proprietary Estimate
Last Quarter Revenue
$8.62B
+5.8% YoY
Gross Margin
68.2%
Net Margin: 21.1%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $8.62B | +5.8% | 68.2% | 30.9% | $1.82B |
| Q4'25 | $9.90B | +8.9% | 81.9% | 39.8% | $1.33B |
| Q3'25 | $9.56B | +12.4% | 67.8% | 26.4% | $3.22B |
| Q2'25 | $9.17B | +9.3% | 67.2% | 28.8% | $1.43B |
| Q1'25 | $8.15B | +9.4% | 63.6% | 14.5% | $1.73B |
| Q4'24 | $9.09B | +10.9% | 65.8% | 25.4% | $627.0M |
| Q3'24 | $8.50B | +23.2% | 61.1% | 24.1% | $2.83B |
| Q2'24 | $8.39B | +20.1% | 61.4% | 22.8% | $746.0M |
Company Information
Symbol
AMGN
Company
AMGEN Inc
Market Cap
$186.16B
Sector
HEALTHCARE
Next Earnings
Aug 4, 2026
Also Reporting Soon
Companies reporting earnings around the same time as AMGN
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare AMGN with competitors
Side-by-side earnings comparison